<DOC>
	<DOCNO>NCT00081705</DOCNO>
	<brief_summary>To measure association estrogen receptor variant extent atherosclerosis thoracic abdominal aorta right coronary artery subject PDAY study .</brief_summary>
	<brief_title>Estrogen Receptor Variants , HDL , Atherosclerosis</brief_title>
	<detailed_description>BACKGROUND : Increased level HDL cholesterol associate low rate clinical anatomic atherosclerosis , even adolescent young adult . In premenopausal woman , estrogen-associated increase HDL may account low rate coronary heart disease ( CHD ) event . Recently , sequence variant estrogen receptor-alpha ( ER-alpha ) gene , ER-alpha IVS1-397 T/C ) , link twofold great increase HDL cholesterol response hormone replacement therapy ( HRT ) . However , remain unclear whether sequence variant also augment HDL level set premenopausal estrogen exposure whether difference translate great reduction atherosclerosis risk . The study use cohort Pathobiology Atherosclerosis Youth ( PDAY ) study , large cross-sectional autopsy study extent atherosclerosis subject age 15 34 year . The detailed description atherosclerotic lesion , combine data cardiovascular risk factor access tissue DNA extraction , make ideal cohort examine association ER-alpha IVS1-397 genotype , HDL level , development early atherosclerosis . DESIGN NARRATIVE : The overall goal study measure association estrogen receptor ( ER- IVS1-401 T/C ) polymorphism extent abdominal aorta , thoracic artery , right coronary artery atherosclerosis Pathobiological Determinants Atherosclerosis Youth ( PDAY ) subject . The investigator use DNA extract liver specimens order measure ER polymorphism . The extent atherosclerosis define percent intimal area involve fatty streak raise lesion , use previously establish PDAY definition . However , percent involvement fatty streak alone percent involvement individual component raise lesion ( fibrous plaque , complicate lesion , calcify lesion ) analyze separately . Available data risk factor ( smoking , diabetes , hyperlipidemia , hypertension ) permit reduce confound result allow adjustment effect major risk factor coronary heart disease . The Department Pathology Louisiana State University Health Sciences Center ( LSUHSC ) designate National Heart , Lung Blood Institute centralize , maintain , distribute valuable material collect combined effort cooperate institution study atherosclerosis . LSUHSC provide DNA polymorphism analysis assist data analysis . Polymorphism determination occur Wake Forest .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>34 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>